Navigation Links
Amerigen Pharmaceuticals and the Shanghai Fosun Omni Pharmaceutical Company Enter Into Collaboration Agreement for the Development of Generic Oral Controlled Release Products
Date:1/11/2012

EAST BRUNSWICK, N.J. and SHANGHAI, Jan. 11, 2012 /PRNewswire/ -- Amerigen Pharmaceuticals Limited ("Amerigen") and the Shanghai Fosun Omni Pharmaceutical Co., Ltd ("Fosun Omni") today announced they had entered into a collaboration agreement regarding the development of generic oral controlled release products. Under the terms of the agreement, Fosun Omni will use its formulation expertise to develop products for Amerigen to commercialize in the United States and other territories. On signing the agreement, Fosun Omni received an up-front fee with respect to the first product and is eligible for additional product-specific development milestones and royalties on any commercialized products.

"This collaboration allows Amerigen to add further momentum to its efforts to build a portfolio of differentiated, high value generic pharmaceuticals," said Jonathan Embleton, Chief Business Officer for Amerigen. "Omni's internationally experienced scientific team will develop complex oral controlled release formulations for scale-up and commercial manufacture at Amerigen's FDA approved facility in Suzhou, which is only a two hour drive from Fosun Omni's operating base in Shanghai's Zhangjiang Hi-Tech Park.

CSO of the Fosun Omni, Dr Ping He, commented, "This collaboration with Amerigen continues Fosun Pharma's strategy to develop some difficult ANDA products to FDA and to speed up the product commercialization process for our partners. This is the first step of the collaboration."

About Amerigen
Amerigen Pharmaceuticals is a group of companies engaged in all phases of the generic pharmaceutical business, with operations in the US and China. The group is controlled by Amerigen Pharmaceuticals Limited. The US regulatory and commercial activities within the group are conducted by Amerigen Pharmaceuticals Inc., based in East Brunswick, NJ, USA. The group's Chinese subsidiary, Suzhou Amerigen Pharmaceuticals Limited, is located in Suzhou, Jiangsu Province. The group has an active portfolio of products under development, filed, or intended for filing, as ANDA's with the US FDA and the Chinese SFDA. Amerigen's focus is orally delivered products that are challenging to develop, require specialized technologies or high containment to manufacture, and present complex regulatory and intellectual property obstacles to bring to market. All Amerigen's products are developed and manufactured by the company or its partners around the world to meet the highest quality standards, including the US FDA.

About Fosun Omni
Shanghai Fosun Omni Pharmaceutical Co., Ltd is a global pharmaceutical company devoted to development, out-licensing, formulation CRO services, and independent R&D for NDA and ANDA projects.  The company focuses are those difficult to develop, manufacture, and replicate oral solid formulations for regulated market and China market at highly competitive prices.


'/>"/>
SOURCE Amerigen Pharmaceuticals Limited
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Amerigen Pharmaceuticals and Stason Pharmaceuticals Enter Into Collaboration Agreement for Development of Generic Oral Oncology Products
2. Amerigen Pharmaceuticals and AustarPharma Enter Into Collaboration Agreement for Generic Oral Controlled Release Products
3. E7: The Outlook for Pharmaceuticals to 2012
4. Oramed Pharmaceuticals Files US Patent Application for Combination Oral Treatment of Diabetes
5. The Outlook for Pharmaceuticals Worldwide
6. Omthera Pharmaceuticals Announces Positive Long Term Bioavailability Data Comparing Epanova™ to Lovaza®
7. Optimer Pharmaceuticals Provides Update on DIFICID® (fidaxomicin) Tablets Launch
8. KalVista Pharmaceuticals and JDRF Form Research Partnership Focused on Novel Approach for Treating Diabetic Eye Disease
9. Questcor Pharmaceuticals Reports Strong Finish to 2011
10. Valeant Pharmaceuticals to Present at 30th Annual J.P. Morgan Healthcare Conference
11. Radient Pharmaceuticals Announces New Advertisement for Oncology Publications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/7/2017)... , Sept. 7, 2017 NuvoAir (formerly ... Spirometer, announced today a partnership with Novartis Pharma AG to ... NuvoAir,s position as the leading mobile spirometry platform and Novartis, ... ... ...
(Date:9/6/2017)... -- Robert G. Szewc, M.D., is recognized by Continental Who,s ... his contributions to the Medical field.      ... practice of Kidney and Hypertension Specialists, which specializes in ... He has worked in this position since 2002, and ... as expertise in kidneys, hypertension, chronic disease and anemia, ...
(Date:9/6/2017)... 2017 NeuroRx, a clinical stage biopharma company developing ... (ASIB), has been granted Fast Track status by the US ... (ketamine HCl) followed by NRX-101 (D-cycloserine + lurasidone). The company ... this sequential therapy targeting patients who are admitted to Emergency ... ...
Breaking Medicine Technology:
(Date:9/23/2017)... ... , ... Silicon Valley Hair Institute, the leading hair transplant center in the ... the ARTAS® hair transplant system and the younger demographic. As many younger people suffer ... methods of hair restoration. , “It can be emotionally difficult for young men and ...
(Date:9/22/2017)... ... September 22, 2017 , ... PITTSBURGH...Defibrillators are used to treat ... if one isn’t accessible in certain locations, the risk of death can be ... with this idea," said an inventor from Ridgecrest, Calif. , The MOBILE AUTOMATED ...
(Date:9/22/2017)... , ... September 22, 2017 , ... ... firm in Pennsylvania, is pleased to offer in-home and online newborn sleep ... sleep deprivation has on the body,” says company owner Courtney Zentz, a pediatric ...
(Date:9/22/2017)... ... , ... “Cursed with a Curse: The Truth about Tithing”: ... experienced when breaking free from this misconception. “Cursed with a Curse: The Truth ... by Christian Faith Publishing, Lysa M. Harrison’s new book is a powerful and ...
(Date:9/22/2017)... Francisco, CA (PRWEB) , ... September 22, 2017 ... ... way to help you brush more effectively even on the go. Their electric ... like gingivitis and gum inflammation, with UV sanitizing technology. Combining leading edge Enke ...
Breaking Medicine News(10 mins):